Mepolizumab for severe eosinophilic asthma - real-life data

被引:0
|
作者
Braganca, M. [1 ]
Amaral, L. [1 ]
Placido, J. L. [1 ]
机构
[1] CHU Sao Joao, Serv Imunoalergol, Porto, Portugal
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
92
引用
收藏
页码:171 / 172
页数:2
相关论文
共 50 条
  • [31] Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients
    Richards, Levi B.
    van Bragt, Job J. M. H.
    Aarab, Reim
    Longo, Cristina
    Neerincx, Anne H.
    Sont, Jaap K.
    Weersink, Els J. M.
    Braunstahl, Gert-Jan
    Ten Brinke, Anneke
    Bel, Elisabeth H. D.
    Maitland-van der Zee, Anke-Hilse
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 2999 - +
  • [32] Mepolizumab for severe eosinophilic asthma
    Robinson, Douglas S.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 13 - 17
  • [33] Mepolizumab for severe eosinophilic asthma - A one-year real life Portuguese study
    Bras, R.
    Paulino, M.
    Varandas, C.
    Coutinho, C.
    Silva, M., I
    Limao, R.
    Costa, C.
    Alonso, E.
    Pedro, E.
    Mendes, A.
    PULMONOLOGY, 2021, 27 (06): : 579 - 581
  • [34] Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
    Scioscia, Giulia
    Tondo, Pasquale
    Nolasco, Santi
    Pelaia, Corrado
    Carpagnano, Giovanna Elisiana
    Caiaffa, Maria Filomena
    Valenti, Giuseppe
    Maglio, Angelantonio
    Papia, Francesco
    Triggiani, Massimo
    Crimi, Nunzio
    Pelaia, Girolamo
    Vatrella, Alessandro
    Barbaro, Maria Pia Foschino
    Crimi, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [35] Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
    Chan, Rory
    Lipworth, Brian J.
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [36] Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype
    Gonzalez-Perez, Ruperto
    Poza-Guedes, Paloma
    Mederos-Luis, Elena
    Sanchez-Machin, Inmaculada
    BIOMEDICINES, 2022, 10 (10)
  • [37] HEALTHCARE RESOURCE USE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA AFTER THE INITIATION OF MEPOLIZUMAB IN REAL-LIFE SETTINGS - REALITI-A STUDY
    Yang, S.
    Maxwell, A.
    Joksaite, S.
    Chaudhuri, R.
    Pastorello, E. A.
    Lee, J.
    Kohler, T. C.
    Ramos-Barbon, D.
    Schleich, F.
    Steven, G.
    Alfonso, R.
    VALUE IN HEALTH, 2020, 23 : S361 - S361
  • [38] Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia
    Emeline Brenard
    Charles Pilette
    Caroline Dahlqvist
    Benoît Colinet
    Florence Schleich
    Florence Roufosse
    Antoine Froidure
    Lung, 2020, 198 : 355 - 360
  • [39] Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia
    Brenard, Emeline
    Pilette, Charles
    Dahlqvist, Caroline
    Colinet, Benoit
    Schleich, Florence
    Roufosse, Florence
    Froidure, Antoine
    LUNG, 2020, 198 (02) : 355 - 360
  • [40] Clinical utility of mepolizumab in real-life practice in severe asthma unit of Madrid (Spain)
    Feijoo Paz, L.
    Garcia-Moguel, I
    Herraez Herrera, L.
    Fernandez Rodriguez, C.
    ALLERGY, 2018, 73 : 671 - 671